APA:
CopyDENT, S., OYAN, B., & HONIG, A.. (2013). HER2-TARGETED THERAPY IN BREAST CANCER: A SYSTEMATIC REVIEW OF NEOADJUVANT TRIALS. CANCER TREATMENT REVIEW, 39(6), 622-631. SID. https://sid.ir/paper/661398/en
Vancouver:
CopyDENT S., OYAN B., HONIG A.. HER2-TARGETED THERAPY IN BREAST CANCER: A SYSTEMATIC REVIEW OF NEOADJUVANT TRIALS. CANCER TREATMENT REVIEW[Internet]. 2013;39(6):622-631. Available from: https://sid.ir/paper/661398/en
IEEE:
CopyS. DENT, B. OYAN, and A. HONIG, “HER2-TARGETED THERAPY IN BREAST CANCER: A SYSTEMATIC REVIEW OF NEOADJUVANT TRIALS,” CANCER TREATMENT REVIEW, vol. 39, no. 6, pp. 622–631, 2013, [Online]. Available: https://sid.ir/paper/661398/en